GlassScriptPhysician profile
Nezar M Falluji
NPI 1053427872
$50,252.68
in general payments reported to CMS, 2019-2025
58 companies · $3,194 in 2025
The $3,194 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $16K · 2021: $4,642 · 2022: $1,692 · 2023: $5,762 · 2024: $2,318 · 2025: $3,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,128 · Travel and Lodging: $3,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,127.78 |
| Travel and Lodging | $3,145.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $19,734.46 | 2019-2025 | Indigo System |
| Bard Peripheral Vascular, INC. | $9,938.53 | 2019-2022 | |
| Edwards Lifesciences Corporation | $7,426.64 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $3,038.25 | 2019-2020 | |
| Medtronic, INC. | $1,412.60 | 2021-2025 | Corevalve Evolut R, Affera Mapping System, Ffrangio |
| Boston Scientific Corporation | $1,037.57 | 2020-2025 | General - Therapies, General - Stents, General - Vascular Intervention |
| Abbott Laboratories | $1,004.28 | 2019-2025 | Ensite, Amplatzer Talisman, Vantageview |
| Janssen Pharmaceuticals, INC | $990.31 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $688.11 | 2019-2025 | |
| Pfizer INC. | $598.79 | 2019-2025 | |
| Ge Healthcare | $452.45 | 2023-2025 | |
| Amgen INC. | $437.39 | 2020-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $315.72 | 2019-2025 | Lokelma, Brilinta, Farxiga |
| Novo Nordisk INC | $313.83 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abiomed | $210.17 | 2024 | Impella |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $162.45 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $149.11 | 2023 | |
| Chiesi USA, INC. | $149.06 | 2019-2021 | |
| Silk Road Medical, INC. | $141.84 | 2022 | |
| Biosense Webster, INC. | $136.90 | 2025 | Carto 3 |
| Angiodynamics, INC. | $135.16 | 2022-2023 | Alphavac |
| Lundbeck LLC | $122.71 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.04 | 2019-2023 | Lifevest |
| Philips North America LLC | $110.30 | 2019-2024 | (5091) Amb Mon & Diag Und, (P84) Igt Devices Systems |
| Merck Sharp & Dohme LLC | $106.83 | 2021-2025 | Verquvo |
| Cordis US Corp. | $106.01 | 2025 | Selution Slr Ptca |
| Atricure, INC. | $102.77 | 2022-2024 | |
| Inspire Medical Systems, INC. | $96.52 | 2025 | Inspire |
| Irhythm Technologies, INC. | $92.64 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Inari Medical, INC. | $75.13 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $62.82 | 2019-2022 | |
| Esperion Therapeutics, INC. | $59.14 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $54.47 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.69 | 2019-2024 | Jardiance |
| Terumo Medical Corporation | $48.56 | 2022-2025 | Angio-Seal, Glidesheath Slender, Glidewire |
| Shockwave Medical, INC | $47.27 | 2022 | |
| Biotronik INC. | $46.37 | 2024 | Amvia Edge |
| Alnylam Pharmaceuticals INC. | $44.65 | 2022-2024 | Onpattro |
| Cardiva Medical, INC. | $41.93 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bardy Diagnostics, INC. | $38.13 | 2020 | |
| Cvrx, INC. | $35.66 | 2023 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $34.84 | 2019 | |
| Scpharmaceuticals INC. | $26.90 | 2023 | |
| Recor Medical INC | $25.30 | 2025 | Paradise Ultrasound Renal Denervation System |
| Impulse Dynamics (USA) INC. | $24.25 | 2024 | Optimizer |
| Organogenesis INC. | $23.53 | 2023 | Puraply |
| Getinge USA Sales, LLC | $21.90 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.72 | 2023 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $17.21 | 2020 | |
| Cardiovascular Systems INC. | $15.83 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $15.71 | 2024 | Arcalyst |
| Imperative Care, INC | $15.56 | 2023 | Symphony Catheter |
| Azurity Pharmaceuticals, INC. | $13.70 | 2024 | Edarbyclor |
| Cardinal Health 200 LLC | $13.66 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.23 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.50 | 2019 | |
| Preventice Services, LLC | $12.23 | 2021 | |
| Surmodics, INC. | $9.35 | 2024 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nezar Falluji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.